U.S. market Closed. Opens in 1 day 9 hours 15 minutes

TAK | Takeda Pharmaceutical Company Limited Stock Financials Income Statements Annual

(Stock Exchange: NYSE)
*Sign In to persist settings
Financial Year End2024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-312007-03-312006-03-312005-03-312004-03-312003-03-312002-03-312001-03-312000-03-31
Revenue4.26T4.03T3.57T3.20T3.29T2.10T1.77T1.73T1.81T1.78T1.69T1.56T1.51T1.42T1.47T1.54T1.37T1.31T1.21T1.12T1.09T1.05T1.01T963.48B923.13B
Cost of Revenue1.94T1.24T1.11T994.31B1.09T659.69B495.92B558.75B535.40B520.99B490.26B447.63B433.19B317.58B285.06B289.54B278.63B279.66B282.10B279.18B269.39B300.34B337.85B384.01B432.33B
Gross Profit2.32T2.78T2.46T2.20T2.20T1.44T1.27T1.17T1.27T1.26T1.20T1.11T1.08T1.10T1.18T1.25T1.10T1.03T930.11B843.78B817.04B745.74B667.21B579.47B490.80B
Operating Expenses1.79T2.29T2.00T1.69T2.10T1.28T1.03T1.02T1.14T1.39T1.06T987.13B810.71B734.72B760.69B942.33B673.05B567.00B527.30B458.50B445.40B435.05B385.96B353.37B319.36B
Selling, General & Admin1.05T997.31B886.36B875.66B964.74B717.60BN/AN/AN/AN/AN/A987.13B810.71B734.72B760.69B942.33BN/AN/AN/AN/AN/AN/A385.96BN/A319.36B
Research & Development729.92B633.33B526.09B455.83B492.38B368.30B325.44B312.30B345.93B382.10B341.56BN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Other Operating Expenses-11.05B662.27B588.87B362.74B643.90B908.87B707.38B705.13B795.22B1.00T720.59BN/AN/AN/A1.00MN/A673.05B567.00B527.30B458.50B445.40B435.05BN/A353.37BN/A
Operating Income526.52B490.50B460.84B509.27B100.41B204.97B241.79B155.87B130.83B-129.25B139.27B122.50B265.03B367.08B420.21B306.47B423.12B458.50B402.81B385.28B371.63B310.69B281.24B226.10B171.44B
Other Expenses / Income-480.20B-115.42B-158.27B-143.03B-161.16B-4.51B-24.58B-12.52B-10.29B-16.18B19.58B7.20B-12.55B4.49B-4.38B92.08B153.72B166.88B115.15B55.82B74.51B121.21B92.18B36.97B31.32B
Before Tax Income46.32B375.09B302.57B366.24B-60.75B94.90B217.21B143.35B120.54B-145.44B158.85B129.71B252.48B371.57B415.83B398.55B576.84B625.38B517.96B441.10B446.14B431.90B373.43B263.08B202.76B
Income Tax Expenses-91.41B58.05B72.41B-9.94B-105.04B-14.12B30.50B27.83B37.06B-2.40B49.29B-3.88B125.21B121.33B115.67B161.35B218.77B285.84B201.36B160.23B157.91B157.49B134.89B114.15B81.45B
Net Income144.07B317.02B230.06B376.00B44.24B109.13B186.89B114.94B80.17B-145.78B106.66B131.24B124.16B247.87B297.74B234.38B355.45B335.81B313.25B277.44B285.26B271.76B235.66B146.85B119.62B
Interest Expenses119.53B169.70B166.61B248.63B165.01B48.16B31.93B23.25B31.93B32.88B30.72B3.32B1.88B1.33B1.43B1.62B333.00M247.00M365.00M334.00M359.00M420.00M759.00M1.02B1.19B
Basic Shares Outstanding1.56B1.55B1.56B1.56B1.56B1.92B1.56B1.56B1.57B1.57B1.58B1.58B1.58B1.58B1.58B1.62B1.70B1.74B1.77B1.77B1.77B1.77B1.77B1.77B1.77B
Diluted Shares Outstanding1.58B1.57B1.58B1.57B1.57B1.93B1.57B1.57B1.58B1.57B1.58B1.58B1.58B1.58B1.58B1.62B1.70B1.74B1.77B1.77B1.77B1.77B1.77B1.77B1.77B
EBITDA1.25T1.21T1.05T1.17T687.90B376.38B431.44B388.81B346.54B145.65B402.41B331.79B401.45B477.25B529.67B515.44B606.24B650.72B543.70B469.23B471.62B459.63B399.74B295.63B235.63B
EBITDA Margin29.42%30.02%29.49%36.73%20.90%17.95%24.37%22.45%19.17%8.19%23.79%21.31%26.60%33.62%36.13%33.51%44.10%49.86%44.85%41.79%43.41%43.94%39.77%30.68%25.52%
EBIT172.20B544.77B469.07B614.70B104.20B143.17B249.31B166.02B149.16B-115.30B186.67B130.69B251.25B370.53B414.84B397.36B574.55B621.90B514.98B438.00B443.53B429.67B371.31B262.02B202.26B
EBIT Margin4.04%13.53%13.14%19.22%3.17%6.83%14.08%9.59%8.25%-6.49%11.03%8.39%16.65%26.10%28.30%25.83%41.79%47.65%42.48%39.00%40.82%41.07%36.94%27.20%21.91%
Financial Year End2024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-312007-03-312006-03-312005-03-312004-03-312003-03-312002-03-312001-03-312000-03-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙